Cargando…

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

The poor outcomes in infant acute lymphoblastic leukemia (ALL) necessitate new treatments. Here we discover that EIF4E protein is elevated in most cases of infant ALL and test EIF4E targeting by the repurposed antiviral agent ribavirin, which has anticancer properties through EIF4E inhibition, as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urtishak, Karen A., Wang, Li-San, Culjkovic-Kraljacic, Biljana, Davenport, James W., Porazzi, Patrizia, Vincent, Tiffaney L., Teachey, David T., Tasian, Sarah K., Moore, Jonni S., Seif, Alix E., Jin, Shenghao, Barrett, Jeffrey S., Robinson, Blaine W., Chen, I-Ming L., Harvey, Richard C., Carroll, Martin P., Carroll, Andrew J., Heerema, Nyla A., Devidas, Meenakshi, Dreyer, ZoAnn E., Hilden, Joanne M., Hunger, Stephen P., Willman, Cheryl L., Borden, Katherine L. B., Felix, Carolyn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440839/ https://www.ncbi.nlm.nih.gov/pubmed/30478448 http://dx.doi.org/10.1038/s41388-018-0567-7

Ejemplares similares

KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study
por: Robinson, Blaine W., et al.
Publicado: (2023)

The Impact of Post-transcriptional Control: Better Living Through RNA Regulons
por: Culjkovic-Kraljacic, Biljana, et al.
Publicado: (2018)

Sonic Hedgehog factor Gli1: As good as resistant
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2015)

eIF4E3, a new actor in mRNA metabolism and tumor suppression
por: Volpon, Laurent, et al.
Publicado: (2013)

The Cap-Binding Complex CBC and the Eukaryotic Translation Factor eIF4E: Co-Conspirators in Cap-Dependent RNA Maturation and Translation
por: Mars, Jean-Clement, et al.
Publicado: (2021)

Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial
por: Guest, Erin M., et al.
Publicado: (2022)

Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine
por: Assouline, Sarit, et al.
Publicado: (2023)

To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity
por: Borden, KLB, et al.
Publicado: (2021)

A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery
por: Volpon, Laurent, et al.
Publicado: (2017)

Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer
por: Culjkovic, Biljana, et al.
Publicado: (2009)

The eukaryotic translation initiation factor eIF4E elevates steady-state m(7)G capping of coding and noncoding transcripts
por: Culjkovic-Kraljacic, Biljana, et al.
Publicado: (2020)

The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
por: Ghram, Mehdi, et al.
Publicado: (2023)

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
por: Burke, Michael J., et al.
Publicado: (2019)

eIF4E is a central node of an RNA regulon that governs cellular proliferation
por: Culjkovic, Biljana, et al.
Publicado: (2006)

eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR
por: Culjkovic, Biljana, et al.
Publicado: (2005)

The eIF4E RNA regulon promotes the Akt signaling pathway
por: Culjkovic, Biljana, et al.
Publicado: (2008)

The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2017)

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia
por: Evensen, Nikki A., et al.
Publicado: (2018)

Long-term Results Of the Pediatric Oncology Group Studies For Childhood Acute Lymphoblastic Leukemia 1984-2001: A Report From The Children’s Oncology Group
por: Salzer, Wanda L., et al.
Publicado: (2009)

Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
por: Bride, Karen L., et al.
Publicado: (2021)

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
por: Tasian, Sarah K., et al.
Publicado: (2014)

Long Term Results of the Children’s Cancer Group Studies for Childhood Acute Lymphoblastic Leukemia 1983–2002: a Children’s Oncology Group Report
por: Gaynon, Paul S., et al.
Publicado: (2009)

The sonic hedgehog factor Gli1 imparts drug resistance through inducible glucuronidation
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2014)

VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group
por: Winter, Stuart S., et al.
Publicado: (2022)

Text Mining and Data Modeling of Karyotypes to aid in Drug Repurposing Efforts
por: Abrams, Zachary B., et al.
Publicado: (2015)

Promyelocytic Leukemia with No Retinoic Acid Receptor Alpha Abnormality but with RUNX1T1 Insertion to Chromosome 7q: A Classification and Management Dilemma
por: Overholt, Kathleen, et al.
Publicado: (2015)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

CD38 as a pan-hematologic target for chimeric antigen receptor T cells
por: Glisovic-Aplenc, Tina, et al.
Publicado: (2023)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA
por: Liu, Yu, et al.
Publicado: (2017)

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232
por: DiNofia, Amanda M., et al.
Publicado: (2017)

MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
por: Matlawska-Wasowska, Ksenia, et al.
Publicado: (2016)

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)

Prolactin and Prolactin Receptor Expression in Rat, Small Intestine, Intraepithelial Lymphocytes During Neonatal Developmen
por: Urtishak, Sandra L., et al.
Publicado: (2001)

S107: IDENTIFICATION AND CHARACTERIZATION OF GERMLINE NBN VARIANTS RELATED TO B-ALL PREDISPOSITION
por: Escherich, Carolin, et al.
Publicado: (2023)

The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C
por: Abenavoli, Ludovico, et al.
Publicado: (2011)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Novel t(1;2)(p36.1;q23) and t(7;19)(q32;q13.3) chromosomal translocations in ischemic fasciitis: expanding the spectrum of pseudosarcomatous lesions with clonal pathogenetic link
por: Sachak, Taha, et al.
Publicado: (2018)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8rvip6r49g8q1o5bok7iu6568q